The Republic Of Korea National Red Cross

The Republic of Korea National Red Cross, doing business as Gyeonggi Blood Center Red Cross, operates as a prime contractor and non-profit international organization providing blood products—apheresis platelets in 250 milliliter units and whole blood units—to the Defense Health Agency to support Department of Defense medical operations and U.S. military healthcare facilities in South Korea. The vendor competes full-and-open with no set-aside designations across its entire federal footprint.

The vendor holds a single-award Blanket Purchase Agreement valued at $249,000 with the Defense Health Agency, established July 1, 2022, and running through June 30, 2027, under which it has received 17 BPA calls since the agreement's award. Individual call orders typically range from $8,000 to $12,000 and are issued on a quarterly or semi-annual basis. Recent calls include $8,910.38 (April 1, 2026), $8,910.38 (January 1, 2026), $8,773.71 (October 2, 2025), $9,267.40 (July 1, 2025 and April 1, 2025), $9,193.14 (January 1, 2025), and $8,954.05 (October 1, 2024). The vendor's customer base is narrowly concentrated: the Defense Health Agency accounts for 17 of 18 awards ($387,000 combined potential value, 97% of the total footprint), with the Department of the Army Medical Command placing a single call order valued at $10,000. Combined potential value across all awards stands at $397,000, with $148,000 obligated to date (37% of potential value).

All work is performed entirely at the contractor's facilities in Suwon, Gyeonggi-do, South Korea, serving Brian Allgood Army Community Hospital and other Department of Defense medical facilities with U.S. personnel stationed in South Korea. The BPA structure uses firm fixed-price ordering with no major subcontractors. Activity has been relatively stable across the past five fiscal years—three awards in 2022, four in 2023, five in 2024, four in 2025, and two in 2026 (through April). The vendor has no subcontract presence in the source data and holds no parent contracts, IDIQs, GWACs, or other vehicles beyond the single Defense Health Agency BPA.